MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2016 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
26 M |
Marktkapitalisierung |
$ 126 M |
EBITDA (LTM) |
$ -156 M |
P/E (LTM) |
- |
P/S (LTM) |
45.026794 |
EPS (LTM) |
-4.94 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
TG Therapeutics
TGTX
|
$ 64.27 | 1.4 % | $ 9.28 B | Nasdaq Capital Market | USA |
 |
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | USA |
 |
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 14.92 | -2.55 % | $ 2.01 B | Nasdaq Global Market | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
- | 2.07 % | $ 34.4 M | Nasdaq Capital Market | USA |
 |
Cerecor Inc.
CERC
|
- | -1.68 % | $ 283 M | Nasdaq Capital Market | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
- | - | $ 1.63 B | Nasdaq Global Select Market | USA |
 |
Auris Medical Holding Ltd.
EARS
|
- | -1.77 % | $ 39.2 M | Nasdaq Capital Market |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
- | 0.34 % | $ 2.98 B | Nasdaq Global Select Market,SPB | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
- | 1.3 % | $ 27.7 M | Nasdaq Global Select Market |  France |
 |
GW Pharmaceuticals plc
GWPH
|
- | - | $ 6.81 B | Nasdaq Global Select Market |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
- | - | $ 1.7 B | Nasdaq Global Select Market | USA |
 |
Liminal BioSciences
LMNL
|
- | - | $ 256 M | Nasdaq Global Market | Canada |
 |
argenx SE
ARGX
|
$ 972.42 | 1.05 % | $ 59.6 B | Nasdaq Global Select Market |  Niderland |
 |
XBiotech
XBIT
|
$ 1.97 | 3.2 % | $ 60.1 M | Nasdaq Global Select Market | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
- | -2.54 % | $ 57.2 M | Nasdaq Global Market | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
- | -3.18 % | $ 58.5 M | Nasdaq Global Select Market | USA |
 |
Orphazyme A/S
ORPH
|
- | -2.25 % | $ 31.3 M | Nasdaq Global Select Market |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
- | -10.74 % | $ 89.9 M | Nasdaq Global Select Market | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Xenetic Biosciences
XBIO
|
$ 1.76 | -2.09 % | $ 2.99 M | Nasdaq Capital Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 30.86 | 2.22 % | $ 3.14 B | Nasdaq Capital Market | USA |
 |
Translate Bio, Inc.
TBIO
|
- | - | $ 2.81 B | Nasdaq Global Select Market,SPB | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
- | - | $ 1.94 B | Nasdaq Capital Market | Canada |
 |
Urovant Sciences Ltd.
UROV
|
- | - | $ 532 M | Nasdaq Global Select Market | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
- | - | $ 10.9 B | Nasdaq Global Market,SPB | USA |
 |
Zealand Pharma A/S
ZEAL
|
- | 0.52 % | $ 821 M | Nasdaq Global Select Market | Danmark |
 |
Zogenix, Inc.
ZGNX
|
- | -4.97 % | $ 664 M | Nasdaq Global Market,SPB | USA |
|
Yunhong International
ZGYH
|
- | 0.10 % | $ 92.2 M | Nasdaq Capital Market |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
- | -7.58 % | $ 264 M | Nasdaq Global Select Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 41.4 | 2.35 % | $ 3.28 B | Nasdaq Global Select Market | Canada |
 |
Leap Therapeutics
LPTX
|
- | 368.57 % | $ 41.9 M | Nasdaq Global Market | USA |
 |
Zymeworks
ZYME
|
$ 31.45 | 2.08 % | $ 1.62 B | NYSE | Canada |
 |
Adial Pharmaceuticals
ADIL
|
$ 3.15 | -35.42 % | $ 2.11 M | Nasdaq Capital Market | USA |
 |
ADMA Biologics
ADMA
|
$ 12.67 | -0.98 % | $ 3.02 B | Nasdaq Global Market | USA |
 |
Cortexyme
CRTX
|
- | -1.05 % | $ 67.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.66 | -1.35 % | $ 802 M | NYSE | Britain |
 |
Daré Bioscience
DARE
|
$ 0.69 | 1.75 % | $ 7.71 M | Nasdaq Capital Market | USA |
 |
Fate Therapeutics
FATE
|
$ 1.78 | -8.51 % | $ 211 M | Nasdaq Global Market,SPB | USA |
 |
Greenwich LifeSciences
GLSI
|
$ 16.05 | -2.85 % | $ 217 M | Nasdaq Capital Market | USA |
 |
Halozyme Therapeutics
HALO
|
$ 103.0 | 0.08 % | $ 12.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 15.34 | 0.1 % | $ 13.2 B | Nasdaq Global Select Market | China |
 |
Aptorum Group Limited
APM
|
- | - | $ 5.72 M | Nasdaq Global Select Market | China |
 |
iBio
IBIO
|
$ 0.78 | -1.89 % | $ 81.2 M | NYSE American | USA |
 |
Kodiak Sciences
KOD
|
$ 108.01 | 0.85 % | $ 5.75 B | Nasdaq Global Market,SPB | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.02 | -54.5 % | $ 219 | Nasdaq Global Select Market | USA |
 |
FSD Pharma
HUGE
|
- | 5743.5 % | $ 69.7 M | Nasdaq Capital Market | Canada |